NCT00032773View on ClinicalTrials.gov

Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 30, 2002

Primary Completion Date

November 3, 2005

Study Completion Date

November 3, 2005

Conditions
Acute Graft Versus Host Disease
Interventions
DRUG

pentostatin for injection

Trial Locations (1)

Unknown

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY